188-0551 Spray

DRUG3 trials

Sponsors

Therapeutics, Inc.

Conditions

Plaque Psoriasis

Phase 2

A Safety Study of 188-0551 Spray Versus Reference Listed Drug (RLD) in Adult Subjects With Plaque Psoriasis

CompletedNCT04080206

Therapeutics, Inc.Plaque Psoriasis

Start: 2020-04-07End: 2021-01-20Updated: 2021-05-10

Phase 3

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

CompletedNCT03731052

Therapeutics, Inc.Plaque Psoriasis

Start: 2018-10-16End: 2019-12-20Updated: 2020-02-25

A Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis

CompletedNCT03759197

Therapeutics, Inc.Plaque Psoriasis

Start: 2018-11-26End: 2019-08-27Updated: 2020-02-25